Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs.
Repository Usage Stats
Existing in vitro models of human skeletal muscle cannot recapitulate the organization and function of native muscle, limiting their use in physiological and pharmacological studies. Here, we demonstrate engineering of electrically and chemically responsive, contractile human muscle tissues ('myobundles') using primary myogenic cells. These biomimetic constructs exhibit aligned architecture, multinucleated and striated myofibers, and a Pax7(+) cell pool. They contract spontaneously and respond to electrical stimuli with twitch and tetanic contractions. Positive correlation between contractile force and GCaMP6-reported calcium responses enables non-invasive tracking of myobundle function and drug response. During culture, myobundles maintain functional acetylcholine receptors and structurally and functionally mature, evidenced by increased myofiber diameter and improved calcium handling and contractile strength. In response to diversely acting drugs, myobundles undergo dose-dependent hypertrophy or toxic myopathy similar to clinical outcomes. Human myobundles provide an enabling platform for predictive drug and toxicology screening and development of novel therapeutics for muscle-related disorders.
human skeletal muscle
Reproducibility of Results
Published Version (Please cite this version)10.7554/eLife.04885
Publication InfoBursac, Nenad; Juhas, M; Kraus, William Erle; Madden, L; & Truskey, George A (2015). Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. Elife, 4. pp. e04885. 10.7554/eLife.04885. Retrieved from https://hdl.handle.net/10161/9364.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Professor of Biomedical Engineering
Bursac's research interests include: Stem cell, tissue engineering, and gene based therapies for heart and muscle regeneration; Cardiac electrophysiology and arrhythmias; Organ-on-chip and tissue engineering technologies for disease modeling and therapeutic screening; Small and large animal models of heart and muscle injury, disease, and regeneration. The focus of my research is on application of pluripotent stem cells, tissue engineering, and gene therapy technologies for: 1) basic s
Richard and Pat Johnson University Professor
My training, expertise and research interests range from human integrative physiology and genetics to animal exercise models to cell culture models of skeletal muscle adaptation to mechanical stretch. I am trained clinically as an internist and preventive cardiologist, with particular expertise in preventive cardiology and cardiac rehabilitation. My research training spans molecular biology and cell culture, molecular genetics, and integrative human exercise physiology and metabolism. I pr
R. Eugene and Susie E. Goodson Professor of Biomedical Engineering
My research interests focus upon the effect of physical forces on the function of vascular cells and skeletal muscle, cell adhesion, and the design of engineered tissues. Current research projects examine the effect of endothelial cell senescence upon permeability to macromolecules and the response to fluid shear stress, the development of microphysiological blood vessels and muscles for evaluation of drug toxicity and the design of engineered endothelialized blood vessels and skelet
Alphabetical list of authors with Scholars@Duke profiles.
Showing items related by title, author, creator, and subject.
Magnitude of spinal muscle damage is not statistically associated with exercise-induced low back pain intensity. Arpan, I; Bishop, Mark D; George, Steven Z; Horn, Maggie Elizabeth; Lott, DJ (Spine J, 2011-12)BACKGROUND CONTEXT: Findings on imaging of noncontractile anatomic abnormalities and the intensity of low back pain have weak associations because of false-positive rates among asymptomatic individuals. This association ...
Clark, RV; Walker, AC; O'Connor-Semmes, RL; Leonard, MS; Miller, RR; Stimpson, SA; Turner, SM; ... (11 authors) (J Appl Physiol (1985), 2014-06-15)Current methods for clinical estimation of total body skeletal muscle mass have significant limitations. We tested the hypothesis that creatine (methyl-d3) dilution (D3-creatine) measured by enrichment of urine D3-creatinine ...
Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Austin, S; Bali, Deeksha Sarihyan; Buckley, Anne Frances; Case, Laura Elizabeth; Kishnani, Priya Sunil; Koeberl, Dwight D; Smith, Edward; ... (8 authors) (FASEB J, 2014-05)Effective dosages for enzyme replacement therapy (ERT) in Pompe disease are much higher than for other lysosomal storage disorders, which has been attributed to low cation-independent mannose-6-phosphate receptor (CI-MPR) ...